This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Min Tang: Innovator in HIV Immunization Strategies
Introduction
Min Tang is a notable inventor based in North Potomac, MD (US). He has made significant contributions to the field of immunology, particularly in developing strategies for immunization against the human immunodeficiency virus (HIV). His work focuses on innovative approaches to generate immune responses that can combat HIV infections.
Latest Patents
Min Tang holds a patent for "Human immunodeficiency virus (HIV) immunization strategies employing conformationally-stabilized, surface-occluded peptides comprising a gp41 2F5 epitope in association with lipid." This invention relates to novel peptide immunogens that generate an immune response in mammals against HIV gp41. It also includes pharmaceutical compositions that comprise such immunogens and methods of treating immunodeficiency diseases, especially HIV infection and AIDS, using these pharmaceutical compositions. He has 1 patent to his name.
Career Highlights
Min Tang works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His role involves research and development aimed at improving public health through innovative medical solutions. His expertise in immunology has positioned him as a key figure in the fight against HIV.
Collaborations
Min Tang has collaborated with notable colleagues in his field, including Gilad Ofek and Peter D Kwong. These collaborations have furthered the research and development of effective immunization strategies against HIV.
Conclusion
Min Tang's contributions to HIV immunization strategies highlight his commitment to advancing medical science. His innovative approaches and collaborations are paving the way for new treatments that could significantly impact public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
